Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/04/2012US20120252823 Adenosine receptor agonists, partial agonists, and antagonists
10/04/2012US20120252822 Inhibitors of bruton's tyrosine kinase
10/04/2012US20120252821 Inhibitors of bruton's tyrosine kinase
10/04/2012US20120252820 Methods of treating fungal infections
10/04/2012US20120252819 Solid dispersion formulations and methods of use thereof
10/04/2012US20120252818 Heat shock protein binding compounds, compositions, and methods for making and using same
10/04/2012US20120252817 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES
10/04/2012US20120252816 Use of phosphodiesterase inhibitors for treating multidrug resistance
10/04/2012US20120252815 Inhibitors of sphingosine kinase
10/04/2012US20120252814 Glucokinase Activators
10/04/2012US20120252813 Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
10/04/2012US20120252812 6-pyrimidinyl-pyrimid-4-one derivative
10/04/2012US20120252811 Combinations of therapeutic agents for treating cancer
10/04/2012US20120252810 Fatty acid non-flushing niacin derivatives and their uses
10/04/2012US20120252809 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
10/04/2012US20120252808 Quinoline amide m1 receptor positive allosteric modulators
10/04/2012US20120252807 Arbovirus inhibitors and uses thereof
10/04/2012US20120252806 Inhibitors of akt activity
10/04/2012US20120252805 Novel compounds
10/04/2012US20120252802 (alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
10/04/2012US20120252801 Antifungal compounds
10/04/2012US20120252800 Bicyclic thiazoles as allosteric modulators of mglur5 receptors
10/04/2012US20120252799 Heterocyclic aromatic compounds useful as growth hormone secretagogues
10/04/2012US20120252798 Indole compounds as an inhibitor of cellular necrosis
10/04/2012US20120252797 Isoxazole Compounds As Inhibitors Of Heat Shock Proteins
10/04/2012US20120252796 Compounds for the treatment of dyslipidemia and related diseases
10/04/2012US20120252795 Oral lysophilisates containing pvp/va
10/04/2012US20120252794 Analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor
10/04/2012US20120252793 Intranasal benzodiazepine pharmaceutical compositions
10/04/2012US20120252792 Methods and compositions for modulating rho-mediated gene transcription
10/04/2012US20120252791 Heterocyclic GTP Cyclohydrolase 1 Inhibitors For the Treatment of Pain
10/04/2012US20120252790 Amino-Derivatives As Novel Inhibitors Of Histone Deacetylase
10/04/2012US20120252789 Inhibitors of sphingosine kinase
10/04/2012US20120252788 5ht2c receptor modulators
10/04/2012US20120252787 Administration of an anti-obesity compound to individuals with renal impairment
10/04/2012US20120252786 5ht2c receptor modulator compositions and methods of use
10/04/2012US20120252785 Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity
10/04/2012US20120252784 2,3,4-benzothiadiazepine-2,2-dioxide derivatives
10/04/2012US20120252783 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
10/04/2012US20120252782 Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions
10/04/2012US20120252781 Benzodiazepine Bromodomain Inhibitor
10/04/2012US20120252780 Bicyclic pyridines and analogs as sirtuin modulators
10/04/2012US20120252779 Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors
10/04/2012US20120252778 Pyrazolo pyrimidine derivatives
10/04/2012US20120252777 Thiazolopyrimidine compounds
10/04/2012US20120252776 C4 Monomethyl Triterpenoid Derivatives and Methods of Use Thereof
10/04/2012US20120252775 Method for diagnosing, preventing, and treating neurological diseases
10/04/2012US20120252774 Steroid tetrol solid state forms - 2
10/04/2012US20120252773 Method and composition for inhibiting cell proliferation and angiogenesis
10/04/2012US20120252772 Cucurbitane-Triterpenoid Compounds, Pharmaceutical Composition, Use and Preparation Method Thereof
10/04/2012US20120252771 Implants and methods for treating inflammation-mediated conditions of the eye
10/04/2012US20120252770 Chemical Compounds 572
10/04/2012US20120252769 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
10/04/2012US20120252768 Composition containing protopanaxatriol and protopanaxadiol
10/04/2012US20120252767 Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
10/04/2012US20120252765 Use of irbesartan for the preparation of a medicament for the prevention of hospitalization for heart failure
10/04/2012US20120252764 Compositions and methods for protecting cells from toxic exposures
10/04/2012US20120252763 Novel group of stat3 pathway inhibitors and cancer stem cell pathway inhibitors
10/04/2012US20120252762 Anti-cancer agent
10/04/2012US20120252761 Kinase inhibitors
10/04/2012US20120252760 Novel pyridopyrazines and their use as modulators of kinases
10/04/2012US20120252759 Thiazole derivatives for the treatment of diseases such as cancer
10/04/2012US20120252758 Novel Bicyclic Pyridinones
10/04/2012US20120252756 Pharmaceutical Compositions and Methods for Treating, Controlling, Ameliorating, or Reversing Conditions of the Eye
10/04/2012US20120252755 Compositions and methods for disinfecting materials
10/04/2012US20120252754 Candy Cakes
10/04/2012US20120252753 Therapeutic target for pancreatic cancer cells
10/04/2012US20120252752 Compositions, methods and kits for repressing virulence in gram positive bacteria
10/04/2012US20120252751 Anti-viral nucleoside analogs and methods for treating viral infections, especially hiv infections
10/04/2012US20120252750 Formulations for reducing neuronal degeneration
10/04/2012US20120252749 Methods of Treating Cancer with Glut Inhibitors
10/04/2012US20120252748 Methods and compositions for determining the responsiveness of cancer therapeutics
10/04/2012US20120252747 Macrocyclic compounds and methods of making and using the same
10/04/2012US20120252746 Methods for Internally Controlling or Treating Equine BOT Larvae
10/04/2012US20120252745 Novobiocin analogues having modified sugar moieties
10/04/2012US20120252744 Pharmaceutical Composition and Method for Neoangiogenesis/Revascularization Useful in Treating Ischemic Heart Disease
10/04/2012US20120252740 Hdac inhibitors and therapeutic methods of using same
10/04/2012US20120252737 Methods for Diagnosing and Treating Cancer
10/04/2012US20120252736 Methods involving pdgfrbeta inhibitors
10/04/2012US20120252733 Use of targeted nitroxide agents in bone healing
10/04/2012US20120252726 Novel neurotrophic factors
10/04/2012US20120252725 Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders
10/04/2012US20120252723 Regulating the Amino Acid Pool Used for the Acute-Phase Protein Synthesis
10/04/2012US20120252721 Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
10/04/2012US20120252720 Compositions for treatment of ear disorders and methods of use thereof
10/04/2012US20120252718 Compositions and Methods for Regulating Cytochrome c-Mediated Apoptosis by tRNA
10/04/2012US20120252667 Insecticidal 4-amino-thieno[2,3-d]-pyrimidine compounds and methods of their use
10/04/2012US20120251642 System and Method for Continuous Extraction of Material
10/04/2012US20120251638 Nutritional Supplement Comprising Nut Oil Composition
10/04/2012US20120251637 Abuse-proofed dosage form
10/04/2012US20120251633 Amino Acid Composition With Improved Dispersibility
10/04/2012US20120251632 Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefrom
10/04/2012US20120251630 Remission therapy of cancer with isoflavonoids
10/04/2012US20120251629 Methods of treatment and screening assays for hif-1alpha regulation
10/04/2012US20120251624 Novel inhibitors of arachidonic acid formation
10/04/2012US20120251623 Method of administering an active ingredient using a chewable oral dosage from comprising texture masked particles
10/04/2012US20120251621 Nutritionally Enhanced Fraction From Rice Bran And Method of Lowering Insulin Resistance Using Same
10/04/2012US20120251620 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
10/04/2012US20120251619 MicroRNA-29a,b,c as a Tumor Suppressor and Sensitizing Agent for Chemotherapy
10/04/2012US20120251618 Delivery and formulation of engineered nucleic acids
1 ... 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 ... 7860